glp-1 cardiovascular outcomes 2025 news Beyond Blood Sugar: A Scoping Review of Receptor Agonists in Care glp-1 cardiovascular outcomes 2025 news

"The WHO even notes that no level of alcohol intake is safe, due to concerns regarding increased risk of cancer with one to two drinks per day," says Johnson-Rabbett

JourneyLite patients receive education, nutritional guidance, follow-up care, and long-term support designed to help them use their procedure effectively for years to come

Monitoring your health while using a GLP-1 receptor agonist is important, and certain symptoms or situations, such as the ones below, should prompt a consultation with a doctor: New or worsening gastrointestinal symptoms, such as persistent nausea, vomiting, diarrhoea, or signs of dehydration 7 , 27

Outcomes: AUD diagnosis and/or alcohol-related hospitalization, preferentially reported as hazard ratios (HRs) with 95% confidence intervals (CIs)